Jubilant Considers Splitting Itself Into Two for Greater Focus

 
• By Aidan Fry

Jubilant’s board is considering whether to create separate entities for its Pharmaceuticals and Life Science Ingredients business segments to give each greater focus.

Croissant
Jubilant is considering whether to divide its business in two, splitting off its Pharmaceuticals business • Source: Shutterstock

More from Earnings

More from Business